Maureen Egan1, Glenn T Furuta2. 1. Section of Pediatric Allergy and Immunology, Department of Pediatrics, Children's Hospital of Colorado, Aurora, Colorado; Gastrointestinal Eosinophilic Disease Program, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: maureen.egan@childrenscolorado.org. 2. Gastrointestinal Eosinophilic Disease Program, University of Colorado School of Medicine, Aurora, Colorado; Digestive Health Institute, Department of Pediatrics, Children's Hospital of Colorado, Aurora, Colorado.
Abstract
OBJECTIVE: Eosinophilic gastrointestinal diseases (EGIDs) are a rare group of disorders that can have varied clinical presentations dependent on the involved segment within the gastrointestinal tract. Eosinophilic gastritis presents with abdominal pain or vomiting, eosinophilic gastroenteritis presents with diarrhea and anemia or hypoalbuminemia, and eosinophilic colitis can present with diarrhea or bloody stools. These nonspecific symptoms remain poorly understood in their relation to the underlying pathogenesis, but a significant percentage of patients have atopy. In this review, we discuss the current literature on EGIDs to promote a practical approach to diagnosis and care. DATA SOURCES: Review of published literature. STUDY SELECTIONS: Clinically relevant literature from 1900 through 2018 was obtained from a PubMed search. Those that addressed prevalence, diagnosis, clinical manifestations, natural history, and treatment of EGIDs were reviewed and are summarized in this article. RESULTS: Of the 485 articles found in the search, most of which were case reports, 71 were selected for review. The natural history of EGIDs is based primarily on case series and small numbers of patients, making therapeutic decisions difficult. Treatment remains limited to dietary restriction that is not effective in many patients and topical or systemic corticosteroids whose long-term use is to be avoided if possible. CONCLUSION: With the seeming increase in all types of EGIDs, phenotypic descriptions are emerging that will likely promote better understanding of the pathogenesis and identification of novel therapeutic targets.
OBJECTIVE:Eosinophilic gastrointestinal diseases (EGIDs) are a rare group of disorders that can have varied clinical presentations dependent on the involved segment within the gastrointestinal tract. Eosinophilic gastritis presents with abdominal pain or vomiting, eosinophilic gastroenteritis presents with diarrhea and anemia or hypoalbuminemia, and eosinophilic colitis can present with diarrhea or bloody stools. These nonspecific symptoms remain poorly understood in their relation to the underlying pathogenesis, but a significant percentage of patients have atopy. In this review, we discuss the current literature on EGIDs to promote a practical approach to diagnosis and care. DATA SOURCES: Review of published literature. STUDY SELECTIONS: Clinically relevant literature from 1900 through 2018 was obtained from a PubMed search. Those that addressed prevalence, diagnosis, clinical manifestations, natural history, and treatment of EGIDs were reviewed and are summarized in this article. RESULTS: Of the 485 articles found in the search, most of which were case reports, 71 were selected for review. The natural history of EGIDs is based primarily on case series and small numbers of patients, making therapeutic decisions difficult. Treatment remains limited to dietary restriction that is not effective in many patients and topical or systemic corticosteroids whose long-term use is to be avoided if possible. CONCLUSION: With the seeming increase in all types of EGIDs, phenotypic descriptions are emerging that will likely promote better understanding of the pathogenesis and identification of novel therapeutic targets.
Authors: Katie Kennedy; Amanda B Muir; Andrew Grossman; Terri Brown-Whitehorn; Antonella Cianferoni; Jonathan M Spergel; Glenn T Furuta; Benjamin J Wilkins; Michele Shuker; Melanie A Ruffner Journal: J Allergy Clin Immunol Pract Date: 2019-02-11
Authors: Lauren A DiTommaso; Chen E Rosenberg; Michael D Eby; Amy Tasco; Margaret H Collins; John L Lyles; Philip E Putnam; Vincent A Mukkada; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2019-01-14 Impact factor: 10.793
Authors: Evan S Dellon; Kathryn A Peterson; Joseph A Murray; Gary W Falk; Nirmala Gonsalves; Mirna Chehade; Robert M Genta; John Leung; Paneez Khoury; Amy D Klion; Sabine Hazan; Michael Vaezi; Adam C Bledsoe; Sandy R Durrani; Chao Wang; Camilla Shaw; Alan T Chang; Bhupinder Singh; Amol P Kamboj; Henrik S Rasmussen; Marc E Rothenberg; Ikuo Hirano Journal: N Engl J Med Date: 2020-10-22 Impact factor: 91.245
Authors: Evan S Dellon; Nirmala Gonsalves; Marc E Rothenberg; Ikuo Hirano; Mirna Chehade; Kathryn A Peterson; Gary W Falk; Joseph A Murray; Lauren T Gehman; Alan T Chang; Bhupinder Singh; Henrik S Rasmussen; Robert M Genta Journal: Clin Gastroenterol Hepatol Date: 2021-06-02 Impact factor: 11.382